BACKGROUND: The long-term durability and prognostic significance of improvement in renal function after mechanical circulatory support (MCS) has yet to be characterized in a large multicenter population. The primary goals of this analysis were to describe serial post-MCS changes in estimated glomerular filtration rate (eGFR) and determine their association with all-cause mortality. METHODS AND RESULTS: Adult patients enrolled in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) with serial creatinine levels available (n=3363) were studied. Early post-MCS, eGFR improved substantially (median improvement, 48.9%; P<0.001) with 22.3% of the population improving their eGFR by ≥100% within the first few weeks. However, in the majority of patients, this improvement was transient, and by 1 year, eGFR was only 6.7% above the pre-MCS value (P<0.001). This pattern of early improvement followed by deterioration in eGFR was observed with both pulsatile and continuous-flow devices. Interestingly, poor survival was associated with both marked improvement (adjusted hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.19-2.26; P=0.002) and worsening in eGFR (adjusted HR, 1.63; 95% CI, 1.15-2.13; P=0.004). CONCLUSIONS: Post-MCS, early improvement in renal function is common but seems to be largely transient and not necessarily indicative of an improved prognosis. This pattern was observed with both pulsatile and continuous-flow devices. Additional research is necessary to better understand the mechanistic basis for these complex post-MCS changes in renal function and their associated survival disadvantage. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00119834.
BACKGROUND: The long-term durability and prognostic significance of improvement in renal function after mechanical circulatory support (MCS) has yet to be characterized in a large multicenter population. The primary goals of this analysis were to describe serial post-MCS changes in estimated glomerular filtration rate (eGFR) and determine their association with all-cause mortality. METHODS AND RESULTS: Adult patients enrolled in the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) with serial creatinine levels available (n=3363) were studied. Early post-MCS, eGFR improved substantially (median improvement, 48.9%; P<0.001) with 22.3% of the population improving their eGFR by ≥100% within the first few weeks. However, in the majority of patients, this improvement was transient, and by 1 year, eGFR was only 6.7% above the pre-MCS value (P<0.001). This pattern of early improvement followed by deterioration in eGFR was observed with both pulsatile and continuous-flow devices. Interestingly, poor survival was associated with both marked improvement (adjusted hazard ratio [HR], 1.64; 95% confidence interval [CI], 1.19-2.26; P=0.002) and worsening in eGFR (adjusted HR, 1.63; 95% CI, 1.15-2.13; P=0.004). CONCLUSIONS: Post-MCS, early improvement in renal function is common but seems to be largely transient and not necessarily indicative of an improved prognosis. This pattern was observed with both pulsatile and continuous-flow devices. Additional research is necessary to better understand the mechanistic basis for these complex post-MCS changes in renal function and their associated survival disadvantage. CLINICAL TRIAL REGISTRATION: URL: http://www.clinicaltrials.gov. Unique identifier: NCT00119834.
Authors: Satoshi Saito; Stephen Westaby; David Piggot; Sergai Dudnikov; Desiree Robson; Pedro A Catarino; Colin Clelland; Chisato Nojiri Journal: Ann Thorac Surg Date: 2002-10 Impact factor: 4.330
Authors: Javed Butler; Carrie Geisberg; Renee Howser; Peer M Portner; Joseph G Rogers; Mario C Deng; Richard N Pierson Journal: Ann Thorac Surg Date: 2006-05 Impact factor: 4.330
Authors: Umesh N Khot; Micky Mishra; M Hilal Yamani; Nicholas G Smedira; Emil Paganini; Mike Yeager; Tiffany Buda; Patrick M McCarthy; James B Young; Randall C Starling Journal: J Am Coll Cardiol Date: 2003-02-05 Impact factor: 24.094
Authors: James K Kirklin; David C Naftel; Robert L Kormos; Lynne W Stevenson; Francis D Pagani; Marissa A Miller; J Timothy Baldwin; James B Young Journal: J Heart Lung Transplant Date: 2012-02 Impact factor: 10.247
Authors: Andrew S Levey; Josef Coresh; Tom Greene; Lesley A Stevens; Yaping Lucy Zhang; Stephen Hendriksen; John W Kusek; Frederick Van Lente Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Sigrid E Sandner; Daniel Zimpfer; Philipp Zrunek; Daniela Dunkler; Heinrich Schima; Angela Rajek; Michael Grimm; Ernst Wolner; Georg M Wieselthaler Journal: J Heart Lung Transplant Date: 2008-05 Impact factor: 10.247
Authors: Sigrid E Sandner; Daniel Zimpfer; Philipp Zrunek; Angela Rajek; Heinrich Schima; Daniela Dunkler; Michael Grimm; Ernst Wolner; Georg M Wieselthaler Journal: Ann Thorac Surg Date: 2009-04 Impact factor: 4.330
Authors: Chiyo Ootaki; Michifumi Yamashita; Yoshio Ootaki; Keiji Kamohara; Stephan Weber; Ryan S Klatte; William A Smith; Alex L Massiello; Steven N Emancipator; Leonard A R Golding; Kiyotaka Fukamachi Journal: J Thorac Cardiovasc Surg Date: 2008-05-19 Impact factor: 5.209
Authors: Samuel T Coffin; Dia R Waguespack; Nicholas A Haglund; Simon Maltais; Jamie P Dwyer; Mary E Keebler Journal: Cardiorenal Med Date: 2015-01-09 Impact factor: 2.041
Authors: Lauren K Truby; Maryjane A Farr; A Reshad Garan; Raymond Givens; Susan W Restaino; Farhana Latif; Hiroo Takayama; Yoshifumi Naka; Koji Takeda; Veli K Topkara Journal: Circulation Date: 2019-06-17 Impact factor: 29.690
Authors: Amrut V Ambardekar; Mary C M Weiser-Evans; Marcella Li; Suneet N Purohit; Muhammad Aftab; T Brett Reece; Karen S Moulton Journal: Circ Heart Fail Date: 2018-05 Impact factor: 8.790
Authors: Suneet N Purohit; William K Cornwell; Jay D Pal; JoAnn Lindenfeld; Amrut V Ambardekar Journal: Circ Heart Fail Date: 2018-06 Impact factor: 8.790